COVID-19 Occupational Webinar Series: April 23rd Updates

Posted on Behalf of  Olivia Leleck

 

As part of Cardno ChemRisk’s support during the COVID-19 pandemic, we are offering bi-weekly complimentary webinars to the general public to help inform the participants on the latest issues, available resources, and updated recommendations on COVID-19. Some of the topics discussed on our April 23rd webinar include:

Antimicrobial Agents & SARS-CoV-2

As a result of the current pandemic, many companies have a new or heightened need for the use of antimicrobial agents. Antimicrobials are essential for public health, but it is critical to also consider the safety of their use and the need to protect those potentially exposed to these chemicals.

When selecting the appropriate antimicrobials, employers should consider the setting (e.g., industry or facility type), uses and application methods, regulatory aspects, and the chemical classes. The EPA’s List provides a list of products approved for use against SARS-CoV-2, the disease that causes COVID-19. Although these products are approved by the EPA, it is important for employers to evaluate and understand the potential health risks prior to their use in the workplace.

Due to the risks associated with COVID-19, some companies may also be interested in novel applications of antimicrobials, using mixtures of chemicals, or employing alternative disinfection methods such as UVC light. Each of these scenarios presents unique risks that must be evaluated to ensure worker health and safety.

When evaluating the use of antimicrobials in the workplace, Cardno ChemRisk can help clients with the following key actions:

· Understanding the hazards
· Characterizing the exposure profiles
· Evaluating or developing exposure recommendations
· Developing comprehensive risk management plans to control exposures

COVID-19 Updates: Plans to Reopen

Some countries and states are releasing plans to reopen as they begin to flatten the curve. The timing for reopening will be local/regional, and will likely be decided by policymakers based on pre-selected indicators such as healthcare capacity.

Plans to reopen include varying goals and indicators at the country and state/local levels. National guidance typically includes broad goals, such as test and trace infrastructure, serological testing, syndromic surveillance, and rapid public health response. State and local guidance outline more specific metrics for reopening, such as requiring a decline in new cases for 14 days.

When considering reopening, individual- and employer-level precautions are also important:

· Individual: vulnerability (e.g., comorbidities, immunosuppression), teleworking capacity/limits, travel risks

· Employer: teleworking possibilities, capacity for control measures (e.g., PPE, maintaining social distance), phased reopening, use of common areas, travel risks

To learn more about the ways Cardno ChemRisk can support your business, review our brochure, read our white paper, and follow us on LinkedIn for updates.

For more COVID-19 updates, join our next webinar session on Thursday, May 7th at 10 a.m. PST/1 p.m. EST. Our COVID-19 team will provide an update on the latest information and workplace scenarios that employees should be aware of. Click here to register.